SCHEMBL8289679

SCHEMBL8289679

C=CCNC(=O)C(=O)[C@@H]1CCCCCCCCC[C@H](NC(=O)N[C@H](C(=O)C2CC2)C(C)C)C(=O)N2C[C@@H]3C[C@@H]3[C@H]2C(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8290590 0.87 — —
SCHEMBL8291136 0.87 — —
SCHEMBL8291498 0.81 GAA (0.32) —
SCHEMBL8290411 0.81 GAA (0.32) —
SCHEMBL8257386 0.78 — —
SCHEMBL16297979 0.78 — —
SCHEMBL8289676 0.77 — —
SCHEMBL8291707 0.76 CPB2 (0.30) —
SCHEMBL8291708 0.75 PSMB9 (0.32) —
SCHEMBL8291706 0.75 CPB2 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005030796-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-04-07 — — WO disclosed
Send feedback